Carl L. Gordon, Director, 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 3,690,000 shares at $2.42 ($8.9M) on 2022-08-16, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.42 | 457,400 | $1.1M | 12.4% |
| 2 | $2.42 | 762,400 | $1.8M | 20.7% |
| 3 | $2.42 | 2,470,200 | $6.0M | 66.9% |
| Total | $2.42 avg | 3,690,000 | $8.9M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |